Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Neuroimage
|
March 26, 2013
EEG alpha activity is associated with individual differences in post-break improvement
Julian Lim, Frances-Catherine Quevenco, Kenneth Kwok
Clinical Chemistry and Laboratory Medicine
|
October 25, 2022
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer's disease
Kaj Blennow, Erik Stomrud, Henrik Zetterberg, et al.
Journal of Alzheimer'S Disease : JAD
|
March 20, 2025
Diagnostic journey and management of patients with mild cognitive impairment and Alzheimer's disease dementia: A multinational, real-world survey
Simona Z Vasileva-Metodiev, Drew Spargo, Eric G Klein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 11, 2023
The potential clinical value of plasma biomarkers in Alzheimer's disease
Kaj Blennow, Douglas Galasko, Robert Perneczky, et al.
JAMA Network Open
|
September 13, 2021
Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis
Julie Martinkova, Frances-Catherine Quevenco, Helene Karcher, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 2, 2022
Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios
Femke H Bouwman, Giovanni B Frisoni, Sterling C Johnson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 15, 2026
Interchangeability of CSF and PET to identify Alzheimer's disease pathology
Samantha C Burnham, Anupa K Arora, Leonardo Iaccarino, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 5, 2025
How can Alzheimer's disease blood-based biomarkers reach clinical practice?
Robert Perneczky, Frances-Catherine Quevenco, James Hendrix, et al.
Brain Communications
|
December 26, 2024
The CSF p-tau/β-amyloid 42 ratio correlates with brain structure and fibrillary β-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease
Raffaele Cacciaglia, Mahnaz Shekari, Gemma Salvadó, et al.
Alzheimer'S Research & Therapy
|
December 20, 2024
Impact of gender on the willingness to participate in clinical trials and undergo related procedures in individuals from an Alzheimer's prevention research cohort
Lidia Canals-Gispert, Alba Cañas-Martínez, Gema Huesa, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Neuroimage
|
March 26, 2013
EEG alpha activity is associated with individual differences in post-break improvement
Julian Lim, Frances-Catherine Quevenco, Kenneth Kwok
Clinical Chemistry and Laboratory Medicine
|
October 25, 2022
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer's disease
Kaj Blennow, Erik Stomrud, Henrik Zetterberg, et al.
Journal of Alzheimer'S Disease : JAD
|
March 20, 2025
Diagnostic journey and management of patients with mild cognitive impairment and Alzheimer's disease dementia: A multinational, real-world survey
Simona Z Vasileva-Metodiev, Drew Spargo, Eric G Klein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 11, 2023
The potential clinical value of plasma biomarkers in Alzheimer's disease
Kaj Blennow, Douglas Galasko, Robert Perneczky, et al.
JAMA Network Open
|
September 13, 2021
Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis
Julie Martinkova, Frances-Catherine Quevenco, Helene Karcher, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 2, 2022
Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios
Femke H Bouwman, Giovanni B Frisoni, Sterling C Johnson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 15, 2026
Interchangeability of CSF and PET to identify Alzheimer's disease pathology
Samantha C Burnham, Anupa K Arora, Leonardo Iaccarino, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 5, 2025
How can Alzheimer's disease blood-based biomarkers reach clinical practice?
Robert Perneczky, Frances-Catherine Quevenco, James Hendrix, et al.
Brain Communications
|
December 26, 2024
The CSF p-tau/β-amyloid 42 ratio correlates with brain structure and fibrillary β-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease
Raffaele Cacciaglia, Mahnaz Shekari, Gemma Salvadó, et al.
Alzheimer'S Research & Therapy
|
December 20, 2024
Impact of gender on the willingness to participate in clinical trials and undergo related procedures in individuals from an Alzheimer's prevention research cohort
Lidia Canals-Gispert, Alba Cañas-Martínez, Gema Huesa, et al.
Page
of 2